The landscape of EGFR pathways and personalized management of non-small-cell lung cancer

By Cheng Liang   Zhang Shaobo   Alexander Riley   Yao Yongxue   MacLennan Gregory T   Pan Chong-xian   Huang Jiaoti   Wang Mingsheng   Montironi Rodolfo   Lopez-Beltran Antonio  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 519-541

Future Medicine

Access to resources Recommend Favorite

Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint

By Stuschke M.   Sak A.   Wurm R.   Sinn B.   Wolf G.   Stüben G.   Budach V.  

International Journal of Radiation Biology, Vol. 78, Iss. 9, 2002-09 ,pp. : 807-819

Informa Healthcare

Access to resources Recommend Favorite

The Role of Irreversible EGFR Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Overcoming Resistance to Reversible EGFR Inhibitors

By Belani Chandra P.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 413-423

Informa Healthcare

Access to resources Recommend Favorite

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds

By Huang Yu   Chen Yu   Mei Qin   Chen Yuan   Yu Shiying   Xia Shu  

Oncology Reports, Vol. 29, Iss. 6, 2013-06 ,pp. : 2486-2492

Spandidos Publications

Access to resources Recommend Favorite

Characterization of the Effects of Cyclooxygenase-2 Inhibition in the Regulation of Apoptosis in Human Small and Non–Small Cell Lung Cancer Cell Lines

By Alam Mahmood   Wang Jiang   Coffey John   Qadri Syed   O’Donnell Aonghus   Aherne Thomas   Redmond Henry  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2678-2684

Springer Publishing Company

Access to resources Recommend Favorite